Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory skin disease characterized by a significant impairment of patients' quality of life (QoL). It has been recently found that clinical severity of HS does not correlate well with QoL. Therefore, it is important to enhance the evaluation of severity considering the disease burden on QoL. Recently, a new graphical tool able to better describe HS burden, the so-called HIDRAdisk, has been introduced.
Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients / Fabbrocini, G; Marasca, C; Megna, M; Peris, K. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 0926-9959. - 33 Suppl 6:S6(2019), pp. 25-27-27. [10.1111/jdv.15821]
Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients
Fabbrocini, G;Marasca, C;Megna, M;
2019
Abstract
Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory skin disease characterized by a significant impairment of patients' quality of life (QoL). It has been recently found that clinical severity of HS does not correlate well with QoL. Therefore, it is important to enhance the evaluation of severity considering the disease burden on QoL. Recently, a new graphical tool able to better describe HS burden, the so-called HIDRAdisk, has been introduced.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
